$13.82
-0.01 (-0.07%)
Analyst Consensus
Strong Sell
13
Analysts
Moderate
Coverage
Buy 0 0%
Hold 7 54%
Sell 6 46%
Price Target
Analyst Price Target +554.1% upside
Low Target $73.92
Average Target $90.40
High Target $125.40
Current Price $13.82
Current
$13.82
Target
$90.40
$73.92 $90.40 avg $125.40
Scenario Analysis
Bear Case
$73.92
434.9%
Low target
Base Case
$90.40
+554.1%
Avg target
Bull Case
$125.40
+807.4%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$13.83
-0.1% from high
52-Week Low
$5.69
+142.9% from low
50-Day SMA
$13.74
+0.6% vs SMA
200-Day SMA
$11.59
+19.2% vs SMA
RSI (14)
66.7
Neutral
Target vs 52W High
$90.40
+553.7% vs high
Next Earnings Report
Nov 9, 2026
2d
until earnings
EPS Est: $0.94
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -2.5%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +10.0%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.4%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +13.5%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +176.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.3%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +155.6%